v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Additional Paid - In Capital
Treasury Stock
Accumulated Deficit
Balance beginning of period (in shares) at Dec. 31, 2024   146,932,032      
Balance, beginning of period at Dec. 31, 2024 $ 193,107 $ 147 $ 284,219 $ 0 $ (91,259)
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 13,933   13,933    
Employee stock purchase plan (in shares)   279,795      
Employee stock purchase plan 1,586   1,586    
Issuance of restricted stock, net (in shares)   864,103      
Issuance of restricted stock, net (3,067) $ 1 (3,068)    
Net (loss) income 33,387       33,387
Balance end of period (in shares) at Sep. 30, 2025   148,075,930      
Balance, end of period at Sep. 30, 2025 238,946 $ 148 296,670 $ 0 (57,872)
Treasury stock, ending balance (in shares) at Sep. 30, 2025       0  
Balance beginning of period (in shares) at Jun. 30, 2025   147,924,862      
Balance, beginning of period at Jun. 30, 2025 216,624 $ 148 291,096 $ 0 (74,620)
Treasury stock, beginning balance (in shares) at Jun. 30, 2025       0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 4,919   4,919    
Employee stock purchase plan (in shares)   130,338      
Employee stock purchase plan 737   737    
Issuance of restricted stock, net (in shares)   20,730      
Issuance of restricted stock, net (82)   (82)    
Net (loss) income 16,748       16,748
Balance end of period (in shares) at Sep. 30, 2025   148,075,930      
Balance, end of period at Sep. 30, 2025 $ 238,946 $ 148 296,670 $ 0 (57,872)
Treasury stock, ending balance (in shares) at Sep. 30, 2025       0  
Balance beginning of period (in shares) at Dec. 31, 2025 148,093,920 148,093,920      
Balance, beginning of period at Dec. 31, 2025 $ 256,548 $ 148 299,081 $ 0 (42,681)
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 0     0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share repurchases pursuant to share repurchase plan (in shares)       3,464,399  
Share repurchases pursuant to share repurchase plan $ (12,859)     $ (12,859)  
Share-based compensation expense 2,419   2,419    
Employee stock purchase plan (in shares)   368,108      
Employee stock purchase plan 1,453   1,453    
Issuance of restricted stock, net (in shares)   927,962      
Issuance of restricted stock, net (2,096) $ 1 (2,097)    
Net (loss) income $ (34,383)       (34,383)
Balance end of period (in shares) at Sep. 30, 2026 149,389,990 149,389,990      
Balance, end of period at Sep. 30, 2026 $ 211,082 $ 149 300,856 $ (12,859) (77,064)
Treasury stock, ending balance (in shares) at Sep. 30, 2026 3,464,399     3,464,399  
Balance beginning of period (in shares) at Jun. 30, 2026   149,188,840      
Balance, beginning of period at Jun. 30, 2026 $ 216,003 $ 149 297,094 $ (12,859) (68,381)
Treasury stock, beginning balance (in shares) at Jun. 30, 2026       3,464,399  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 3,204   3,204    
Employee stock purchase plan (in shares)   175,830      
Employee stock purchase plan 617   617    
Issuance of restricted stock, net (in shares)   25,320      
Issuance of restricted stock, net (59)   (59)    
Net (loss) income $ (8,683)       (8,683)
Balance end of period (in shares) at Sep. 30, 2026 149,389,990 149,389,990      
Balance, end of period at Sep. 30, 2026 $ 211,082 $ 149 $ 300,856 $ (12,859) $ (77,064)
Treasury stock, ending balance (in shares) at Sep. 30, 2026 3,464,399     3,464,399